Glucotrack, Inc. Cash And Cash Equivalents At Carrying Value

• Glucotrack, Inc. showed an increase of +31.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Glucotrack, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 18 years of available data (2008 to 2025), Glucotrack, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,302.8%.
• Historical annual values: Fiscal year 2025: $7.38 million | Fiscal year 2024: $5.62 million | Fiscal year 2023: $4.49 million | Fiscal year 2022: $2.31 million | Fiscal year 2021: $6.06 million | Fiscal year 2020: $9.82 million | Fiscal year 2019: $419.0 thousand | Fiscal year 2018: $97.1 thousand | Fiscal year 2017: $53.8 thousand | Fiscal year 2016: $148.8 thousand | Fiscal year 2015: $608.7 thousand | Fiscal year 2014: $5.83 million | Fiscal year 2013: $2.39 million | Fiscal year 2012: $543.4 thousand | Fiscal year 2011: $1.90 million | Fiscal year 2010: $1.49 million | Fiscal year 2009: $62.0 thousand | Fiscal year 2008: $526.3 thousand.
• Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: June 24, 2026